marijuana stock news

Tauriga Sciences, Inc. (TAUG)

 

Income Statement Get Income Statement for:
View: Annual Data | Quarterly Data All numbers in thousands
Period Ending Dec 31, 2014 Sep 30, 2014 Jun 30, 2014 Mar 31, 2014
Total Revenue 29   11   –   –  
Cost of Revenue 9 3 – –
Gross Profit 20   8   –   –  
Operating Expenses
Research Development – – – –
Selling General and Administrative 717 1,054 1,793 1,681
Non Recurring – – – 1,356
Others 30 30 30 63
Total Operating Expenses – – – –
Operating Income or Loss (728) (1,535) (1,365) (3,101)
Income from Continuing Operations
Total Other Income/Expenses Net (600) (712) 343 (1,845)
Earnings Before Interest And Taxes (1,327) (1,788) (1,480) (4,946)
Interest Expense 58 31 95 276
Income Before Tax (1,385) (1,820) (1,576) (5,221)
Income Tax Expense – – – –
Minority Interest – – – –
Net Income From Continuing Ops (1,385) (1,820) (1,576) (5,221)
Non-recurring Events
Discontinued Operations – – – –
Extraordinary Items – – – –
Effect Of Accounting Changes – – – –
Other Items – – – –
Net Income (1,385) (1,820) (1,576) (5,221)
Preferred Stock And Other Adjustments – – – –
Net Income Applicable To Common Shares (1,385) (1,820) (1,576) (5,221)

MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

$MCIG to Acquire Security Grade, Bringing Full-Service Specialized Security Solutions

mCig, Inc. to Acquire Security Grade, Bringing Full-Service Specialized Security Solutions to…

TerrAscend Corp. (TRSSF) Expands Partnership with Cookies to Bring Top-Shelf Genetics to Maryland

TerrAscend Expands Partnership with Cookies to Bring Top-Shelf Genetics to Maryland TerrAscend…

$VHUB Pays Second Installment Of Interest

Vapor Hub International Pays Second Installment Of Interest, Fees Due on Promissory…

$GWPH Announces US Patent Allowance for Use of Cannabidivarin (CBDV)

GW Pharmaceuticals plc Announces US Patent Allowance for Use of Cannabidivarin (CBDV)…